Home > PE Ratio > BIOCON

BIOCON
PE (Price/Earnings) Ratio

The Current P/E Ratio of BIOCON is 21.88.

Share Price ₹344.8Dec 24,2024
Market Cap ₹41,396.7 Cr
Earnings-TTM₹1,891.9 CrTTM-Consolidated Results
Price/Earnings21.88xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BIOCON

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BIOCON is calculated as :

Current Market Cap [ ₹41,396.7 Cr] as on Dec 24,2024

(/) Earnings [ ₹1,891.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 21.88x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BIOCON , the investors are currently willing to pay 21.88 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BIOCON !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BIOCON over the last five years.

Historical PE (Price/Earnings) ratio chart of BIOCON


PE Ratio Performance Analysis for BIOCON

- BIOCON 's latest p/e ratio is 21.88x.

- BIOCON 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 51.23x.

- BIOCON 's operated at median p/e ratio of 53.54x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BIOCON 's p/e ratio peaked in Mar2021 at 66.25x.

- BIOCON 's p/e ratio hit its five-year low in Mar2024 of 31.01x.


How does BIOCON 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BIOCON 1,891.9021.8841,396.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.16436,103.0
CIPLA LTD4,485.2226.58119,196.0
DR REDDYS LABORATORIES LTD5,406.8020.85112,752.0
ZYDUS LIFESCIENCES LTD4,298.9022.5797,041.2
DIVIS LABORATORIES LTD1,836.0083.63153,540.0
MANKIND PHARMA LTD2,124.8656.51120,073.0
TORRENT PHARMACEUTICALS LTD1,802.0063.88115,112.0
LUPIN LTD2,651.9437.3098,925.3
AUROBINDO PHARMA LTD3,598.8320.3773,314.6
ABBOTT INDIA LTD1,284.6647.0860,480.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BIOCON 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.37x
Max industry PE 83.63x
Median industry PE 37.30x
Average industry PE 39.98x



You may also like the below Video Courses